Paradeep Phosphates reports FY26 revenue of ₹21,826 crore, PAT up 52% YoY
Paradeep Phosphates · Fertilizers & Agrochemicals
Key highlights
- FY26 revenue from operations ₹21,826 crore (+29% YoY), EBITDA ₹2,259 crore (+33%), PAT ₹1,000 crore (+52%)
- Production 36.66 LMT (+8% YoY), sales volumes 42.10 LMT (+10%), NPK sales including TSP 24.64 LMT (+22%)
- Long-term credit rating enhanced to AA-(stable); sulphuric acid capacity up 0.6 MMTPA after FY26 commissioning
Why it's rated major development: the year-on-year change is 52% (50% or more)
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other capex / expansion filings this fortnight
- Maharaja & Speedex India Limited raises manufacturing capacity to 72 lakh units/year
- Elin Electronics Q2 FY27 earnings report with 10% revenue growth and margin update
- HOAC Foods India Limited H1 FY27 Earnings Call Transcript dated November 5, 2026
- Gujarat State Fertilizers & Chemicals Limited Q2 FY27 Earnings Call Highlights
- Supriya Lifescience H1 revenue up 14.8% to ₹396.04 crore; Q2 profit falls
- V-MARC India Ltd announces Q2 & H1 FY27 unaudited financial results and review report
Potential multibaggers · Q2 FY27
Potential multibaggers in Fertilizers & Agrochemicals
on management's own guidance
- Madhya Bharat Agro ProductsGood growth2
- Anya Polytech &Good growth1
- Krishana PhoschemGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.